Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Work In Process: 2023-2024

Historic Work In Process for Ligand Pharmaceuticals (LGND) over the last 2 years, with Dec 2024 value amounting to $3.9 million.

  • Ligand Pharmaceuticals' Work In Process rose 1911.79% to $3.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was $3.9 million, marking a year-over-year increase of 1911.79%. This contributed to the annual value of $3.9 million for FY2024, which is 1911.79% up from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Work In Process of $3.9 million as of FY2024, which was up 1,911.79% from $195,000 recorded in FY2023.
  • Over the past 5 years, Ligand Pharmaceuticals' Work In Process peaked at $3.9 million during FY2024, and registered a low of $195,000 during FY2023.
  • In the last 2 years, Ligand Pharmaceuticals' Work In Process had a median value of $2.1 million in 2023 and averaged $2.1 million.
  • Data for Ligand Pharmaceuticals' Work In Process shows a peak YoY skyrocketed of 1,911.79% (in 2024) over the last 5 years.
  • Ligand Pharmaceuticals' Work In Process (Yearly) stood at $195,000 in 2023, then skyrocketed by 1,911.79% to $3.9 million in 2024.